Located in the CNS, postganglionic cell body, and dendrites. Their structure is a pentamer with only ɑ and β subunits. They work through Na+ and K+ depolarization ion channels
Located in the skeletal neuromuscular junction. Their structure is that of a pentamer with ɑ, β, γ, and δ subunits. They work through Na+ and K+ depolarization ion channels
Located in the nerves. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade. Has a stimulatory effect. Innervation causes the brain to increase cognition and memory while the stomach is told to increase pepsinogen and HCl release
Located in the heart, nerves, and smooth muscle. Their structure is a Gi/o protein coupled receptor. They work through cAMP inhibition and activation of K+ channels. Has an inhibitory effect. Causes the SA node to decrease chronotropy, atria to decrease inotropy, AV node to decrease dromotropy/increase refractory period, and the ventricles to decrease inotropy
Located in the glands, smooth muscles, and endothelial cells. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade. Has a stimulatory effect. Causes increased tears, saliva, bronchial secretions and constriction, digestive enzymes, GI mucus and peristalsis, iris miosis and lens, and increases detrusor contraction/trigone and sphincter relaxation
Works by directly acting on M2 and M3 receptor to cause smooth muscle contraction in the airways and increased bronchial secretions during stress tests
Used to diagnosis respiratory diseases, not used as their treatment
May cause bronchoconstriction when given, but has a short duration of action of ~30 minutes
Directly agonizes M1, M2, and M3 receptors leading to ciliary muscle contraction in open-angle glaucoma, opening of the angle in closed-angle glaucoma, and increasing salivary to treat xerostomia
Adverse effects are only hyperhidrosis since they're less likely to occur with eye drops
Autoimmune disease that attacks nicotinic receptors in the skeletal neuromuscular junction. This can happen by receptor cross-linking, lysis of the postsynaptic membrane, and/or binding directly to the receptors and inhibiting their function
Symptoms: Ptosis, diplopia, muscle weakness, and trouble speaking
This disease is treated by AChE inhibitors which increase ACh in the synaptic cleft